Interstitial lung abnormalities in a large clinical lung cancer screening cohort: association with mortality and ILD diagnosis
Avignat S. Patel(Lahey Hospital and Medical Center), Lee Gazourian(Brigham and Women's Hospital), Ezra R. Miller(Pulmonary and Critical Care Associates), Andrea B. McKee(Lahey Hospital and Medical Center), Lori Lyn Price(Tufts University), Víctor Pinto-Plata(St. Elizabeth's Medical Center), Christoph Wald(Lahey Hospital and Medical Center), Kimberly Rieger‐Christ(Lahey Hospital and Medical Center), Timothy Liesching, Melissa Gawlik(Lahey Medical Center), Shawn M. Regis(Lahey Hospital and Medical Center), Jeffrey A. Hashim(Lahey Hospital and Medical Center), Brady J. McKee(Lahey Hospital and Medical Center), Gary M. Hunninghake(Hubei University of Science and Technology)
Cited by 42
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2012|1.3k
Serum Vitamin D Levels and Markers of Severity of Childhood Asthma in Costa Rica
|American Journal of Respiratory and Critical Care Medicine|2009|635
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615
Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society
|The Lancet Respiratory Medicine|2020|575